HIND·92943X104·US·equity·Healthcare - Biotechnology
HIND (VYOME HOLDINGS INC) is held by 5 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($55,454), UBS Group AG ($48,751), Focus Partners Wealth ($31,476). Net institutional sentiment: Mixed.
See how HIND's score breaks down across 4 SEC sources
No recent insider, activist, or congressional trades found for this stock
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer